- AG9801
Trial Status
Closed
Cancer Type
Stomach Cancer
If you think this trial is relevant to your situation, please contact your Cancer Specialist to discuss further.
Protocol Title
A phase II study of irinotecan, leucovorin and 5- fluorouracil in advanced gastric cancer.
Purpose of the Study
This trial was designed to assess the efficacy and toxicity of irinotecan, leucovorin, and 5-flourouracil for patients with advanced gastric cancer.
Principal Investigators
Prof Stephen Ackland
Dr David Storey
Funding
Educational Grant, Pharmacia & Upjohn
DETAILED INFORMATION AVAILABLE
Available online at the Australian New Zealand Clinical Trial Registry (ANZCTR) here
Trial Status
Closed
Cancer Type
Stomach Cancer
If you think this clinical trial may be relevant to your patient or to discuss further, please contact the Clinical Trial team.
Aim
This trial was designed to assess the efficacy and toxicity of irinotecan, leucovorin, and 5-flourouracil for patients with advanced gastric cancer.
Principal Investigator
Professor Stephen Ackland, Medical Oncologist, Newcastle Calvary Mater Hospital, NSW
Dr David Storey, Upper GI Surgeon, Royal Prince Alfred Hospital, NSW
